Rosacea affects an estimated 40 million people worldwide. However, doctors have been hesitant to diagnose and treat it because nothing available provides the effective results patients are looking for. So we needed to a campaign prove to physicians that they now have a topical which delivers the efficacy they and their patients have longed for.

Because Soolantra is the strongest topical available to treat this chronic condition of unknown origin, it needed a campaign that was just as tough and unique. Rosacea has finally met its match with Soolantra. This is why we’ve focused on the age-­old story of the strong versus the weak; how good always wins out over evil or, in this case, how our hero, Soolantra, is strong enough to rise above all other agents to finally eliminate the evil that has plagued its rosacea victims…and has had nothing to fear for far too long.